Abstract
Original language | English |
---|---|
Pages (from-to) | 240-248 |
Number of pages | 9 |
Journal | Acta Reumatológica Portuguesa |
Volume | 2017 |
Issue number | 3 |
Publication status | Published - Jul 2017 |
Keywords
- Early exit from work
- Early retirement
- Rheumatic diseases
- Vocational rehabilitation
Access to Document
- 1169_interventions_aiming_to_reduce_early_retirement_due_to_rheumatic_diseases_fileFinal published version, 198 KBLicence: CC BY-NC-ND
Fingerprint
Dive into the research topics of 'Interventions aiming to reduce early retirement due to rheumatic diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Acta Reumatológica Portuguesa, Vol. 2017, No. 3, 07.2017, p. 240-248.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Interventions aiming to reduce early retirement due to rheumatic diseases
AU - Laires, P.
AU - Gouveia, M
AU - Canhao, Helena
N1 - Export Date: 19 October 2017 CODEN: ARUPB Correspondence Address: Laires, P.; Sociedade Portuguesa de Reumatologia, Av. de Berlim, 33 B, Portugal; email: [email protected] References: (2013), http.//www.who.int/gho/mortality_burden_disease/life_tables/en/index.html, Geneva, World Health Organization; (2011) United Nations, Department of Economic and Social Affairs, Population Division, p. 313. , World Population Prospects. The 2010 Revision, Volume I: Comprehensive Tables. ST/ESA/SER.A; http.//www.pordata.pt/en/Portugal/Pensions+total++Social+Security+and+Public+Administration+Retirement+Fund-851, (until 1998) | ISS/MSESS (as from 1999); https.//www.ine.pt/xportal/xmain?xpgid=ine_main&xpid=INE; Lacaille, D., Hogg, R.S., The effect of arthritis on working life expectancy (2001) J Rheumatol, 28, pp. 2315-2319; Lund, T., Csonka, A., Risk factors in health, work environment, smoking status, and organizational context for work disability (2003) Am J Ind Med, 44, pp. 492-501; Karpansalo, M., Manninen, P., Kauhanen, J., Lakka, T.A., Salonen, J.T., Perceived health as a predictor of early retirement (2004) Scand J Work Environ Health, 30, pp. 287-292; Solomon, C., Poole, J., Palmer, K.T., Coggon, D., Health-related job loss: findings from a community-based survey (2007) Occupational and environmental medicine, 64, pp. 144-149; Westhoff, G., Buttgereit, F., Gromnica-Ihle, E., Zink, A., Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis (2008) Rheumatology (Oxford), 47, pp. 980-984; Schofield, D.J., Shrestha, R.N., Passey, M.E., Earnest, A., Fletcher, S.L., Chronic disease and labour force participation among older Australians (2008) Med J Aust, 189, pp. 447-450; Alavinia, S.M., Burdorf, A., Unemployment and retirement and illhealth: a cross-sectional analysis across European countries (2008) International archives of occupational and environmental health, 82, pp. 39-45; Pit, S.W., Shrestha, R., Schofield, D., Passey, M., Partial and complete retirement due to ill-health among mature age Australians (2013) Pu-blic Health, 127, pp. 561-571; Kivimäki, M., Ferrie, J.E., Hagberg, J., Head, J., Westerlund, H., Vahtera, J., Alexanderson, K., Diagnosis-specific sick leave as a risk mar-ker for disability pension in a Swedish population (2007) J Epidemiol Community Health, 61, pp. 915-920; Jensen, L.D., Ryom, P.K., Christensen, M.V., Andersen, J.H., Differences in risk factors for voluntary early retirement and disability pension: a 15-year follow-up in a cohort of nurses' aides (2012) BMJ Open, 12, pp. 2-6; Li Ranzi, T., d'Errico, A., Costa, G., Association between chronic morbidity and early retirement in Italy (2013) International archives of occupational and environmental health, 86, pp. 295-303; Leijten, F.R., de Wind, A., van den Heuvel, S.G., Ybema, J.F., van der Beek, A.J., Robroek, S.J., Burdorf, A., The influence of chronic health problems and work-related factors on loss of paid employment among older workers (2015) J Epidemiol Community Health, 69, pp. 1058-1065; Nagi, S., Disability concepts revisited. implications for prevention (1991) Disability in America: Toward a National Agenda for Prevention, pp. 309-327. , Pope AM, Tarlov AR, eds. Washington, DC: National Academy Press;; Stattin, M., Retirement on grounds of ill health (2005) Occup Environ Med, 62, pp. 135-140; Yelin, E., Trupin, L., Katz, P., Lubeck, D., Rush, S., Wanke, L., Association between etanercept use and employment outcomes among patients with rheumatoid arthritis (2003) Arthritis Rheum, 48, pp. 3046-3054; Puolakka, K., Kautiainen, H., Mottonen, T., Impact of initial aggressive drug treatment with a combination of disease-mo-difying anti-rheumatic drugs on the development of work di-sability in early rheumatoid arthritis: a five-year randomized follow-up trial (2004) Arthritis Rheum, 50, pp. 55-62; Kobelt, G., Eberhardt, K., Geborek, P., TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden (2004) Ann Rheum Dis, 63, pp. 4-10; Smolen, J.S., Han, C., van der Heijde, D., Emery, P., Bathon, J.M., Keystone, E., Kalden, J.R., St Clair, E.W., Infliximab treatment maintains employability in patients with early rheumatoid arthritis (2006) Arthritis Rheum, 54, pp. 716-722; Wolfe, F., Allaire, S., Michaud, K., The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of antitumor necrosis factor on work disability (2007) J Rheumatol, 34, pp. 2211-2217; Allaire, S., Wolfe, F., Niu, J., Evaluation of the effect of antitumor necrosis factor agent use on rheumatoid arthritis work disa-bility: the jury is still out (2008) Arthritis Rheum, 59, pp. 1082-1089; Cole, J.C., Li, T., Lin, P., MacLean, R., Wallenstein, G.V., Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abata-cept (2008) Rheumatology (Oxford), 47, pp. 1044-1050; Bejarano, V., Quinn, M., Conaghan, P.G., Reece, R., Keenan, A.M., Walker, D., Gough, A., Emery, P., Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Yorkshire Early Arthritis Register Consortium (2008) Arthritis Rheum, 59, pp. 1467-1474; Halpern, M.T., Cifaldi, M.A., Kvien, T.K., Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group (2009) Ann Rheum Dis, 68, pp. 930-937; Augustsson, J., Neovius, M., Cullinane-Carli, C., Eksborg, S., van Vollenhoven, R.F., Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) (2010) Ann Rheum Dis, 69, pp. 126-131; Kristensen, L.E., Petersson, I.F., Geborek, P., Jöud, A., Saxne, T., Jacobsson, L.T., Englund, M., Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study (2012) Rheumatology (Oxford), 51, pp. 243-249; Verstappen, S.M., Watson, K.D., Lunt, M., McGrother, K., Symmons, D.P., Hyrich, K.L., Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register (2010) Rheumatology (Oxford), 49, pp. 1570-1577; van Vollenhoven, R.F., Cifaldi, M.A., Ray, S., Chen, N., Weisman, M.H., Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study (2010) Arthritis Care Res (Hoboken), 62, pp. 226-234; Eriksson, J.K., Neovius, M., Bratt, J., Petersson, I.F., van Vollenhoven, R.F., Geborek, P., Ernestam, S., Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial (2013) JAMA Intern Med, 173, pp. 1407-1414; Eriksson, J.K., Wallman, J.K., Miller, H., Petersson, I.F., Ernestam, S., Vivar, N., van Vollenhoven, R.F., Neovius, M., Infliximab versus Conventional Combination Treatment and 7-Year Work Loss in Early RA: Results of the Randomized Swefot Trial (2016) Arthritis Care Res (Hoboken), 68, pp. 1758-1766; Olofsson, T., Johansson, K., Eriksson, J.K., van Vollenhoven, R., Miller, H., Petersson, I.F., Askling, J., Neovius, M., Does disease activity at start of biologic therapy influence work-loss in RA patients? (2016) Rheumatology (Oxford), 55, pp. 729-734; van der Burg, L.R., Ter Wee, M.M., Boonen, A., Effect of biological therapy on work participation in patients with ankylosing spondylitis: a systematic review (2012) Ann Rheum Dis, 71, pp. 1924-1933; ter Wee, M.M., Lems, W.F., Usan, H., Gulpen, A., Boonen, A., The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review (2012) Ann Rheum Dis, 71, pp. 161-171; Barkham, N., Coates, L.C., Keen, H., Hensor, E., Fraser, A., Redmond, A., Cawkwell, L., Emery, P., Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis (2010) Ann Rheum Dis, 69, pp. 1926-1928; Furuya, H., Kasama, T., Isozaki, T., Umemura, M., Otsuka, K., Isojima, S., Tsukamoto, H., Takahashi, R., Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis (2013) J Multidiscip Healthc, 6, pp. 25-30; Emery, P., Smolen, J.S., Ganguli, A., Meerwein, S., Bao, Y., Kupper, H., Chen, N., Kavanaugh, A., Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate (2016) Rheumatology (Oxford), 55, pp. 1458-1465; Herenius, M.M., Hoving, J.L., Sluiter, J.K., Raterman, H.G., Lems, W.F., Dijkmans, B.A., Tak, P.P., Frings-Dresen, M.H., Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab (2010) J Occup Environ Med, 52, pp. 618-621; Hoving, J.L., Bartelds, G.M., Sluiter, J.K., Sadiraj, K., Groot, I., Lems, W.F., Dijkmans, B.A., Frings-Dresen, M.H., Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation (2009) Scand J Rheumatol, 38, pp. 246-250; Mittendorf, T., Dietz, B., Sterz, R., Cifaldi, M.A., Kupper, H., von der Schulenburg, J.M., Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective (2008) Rheumatology (Oxford), 47, pp. 188-193; Zhang, W., Bansback, N., Guh, D., Li, X., Nosyk, B., Marra, C.A., Anis, A.H., Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis (2008) J Rheumatol, 35, pp. 1729-1736; Anis, A., Zhang, W., Emery, P., Sun, H., Singh, A., Freundlich, B., Sato, R., The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study (2009) Rheumatology (Oxford), 48, pp. 1283-1239; Kavanaugh, A., Smolen, J.S., Emery, P., Purcaru, O., Keystone, E., Richard, L., Strand, V., van Vollenhoven, R.F., Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis (2009) Arthritis Rheum, 61, pp. 1592-1600; Farahani, P., Levine, M., Gaebel, K., Wang, E.C., Khalidi, N., Community-based evaluation of etanercept in patients with rheumatoid arthritis (2006) J Rheumatol, 33, pp. 665-670; van der Heijde, D., Han, C., DeVlam, K., Burmester, G., van den Bosch, F., Williamson, P., Bala, M., Braun, J., Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial (2006) Arthritis Rheum, 55, pp. 569-574; Kavanaugh, A., Antoni, C., Mease, P., Gladman, D., Yan, S., Bala, M., Zhou, B., Krueger, G.G., Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis (2006) J Rheumatol, 33, pp. 2254-2259; Listing, J., Brandt, J., Rudwaleit, M., Zink, A., Sieper, J., Braun, J., Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis (2004) Ann Rheum Dis, 63, pp. 1670-1672; Maksymowych, W.P., Gooch, K.L., Wong, R.L., Kupper, H., van der Heijde, D., Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis (2010) J Rheumatol, 37, pp. 385-392; Allaire, S., Anderson, J., Meenan, R., Outcomes from the job-raising program, a self-improvement model of vocational rehabilitation, among persons with arthritis (1997) Journal of Applied Rehabilitation Counseling, 28, pp. 26-31; Abásolo, L., Blanco, M., Bachiller, J., Candelas, G., Collado, P., Lajas, C., Revenga, M., Jover, J.A., A health system program to reduce work disability related to musculoskeletal disorders (2005) Ann Intern Med, 143, pp. 404-414; Gignac, M.A., Jetha, A., Bowring, J., Beaton, D.E., Badley, E.M., Mana-gement of work disability in rheumatic conditions. a review of non-pharmacological interventions (2012) Best Pract Res Clin Rheumatol, 26, pp. 369-386; van Amelsvoort, L.G., Kant, I.J., Beurskens, A.J., Schroer, C.A., Swaen, G.M., Fatigue as a predictor of work disability (2002) Occup Environ Med, 59, pp. 712-713; de Buck, P.D., le Cessie, S., van den Hout, W.B., Peeters, A.J., Ronday, H.K., Westedt, M.L., Breedveld, F.C., Vliet Vlieland, T.P., Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss (2005) Arthritis Rheum, 53, pp. 682-690; Varekamp, I., Verbeek, J.H., de Boer, A., van Dijk, F.J., Effect of job maintenance training program for employees with chronic disea se-a randomized controlled trial on self-efficacy, job satis-faction, and fatigue (2011) Scand J Work Environ Health, 37, pp. 288-297; Hoving, J.L., Lacaille, D., Urquhart, D.M., Hannu, T.J., Sluiter, J.K., Frings-Dresen, M.H., Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis (2014) Cochrane Database Syst Rev, (11). , Nov 6; Carruthers, E.C., Rogers, P., Backman, C.L., Goldsmith, C.H., Gignac, M.A., Marra, C., Village, J., Lacaille, D., "Employment and arthritis: making it work" a randomized controlled trial evaluating an online program to help people with inflammatory arthritis maintain employment (study protocol) (2014) BMC Med Inform Decis Mak, 21, pp. 14-59; Keysor, J., (2013) Efficacy of a Modified Vocational Rehabilitation Intervention for Work Disability, , Ongoing study Ongoing (unpublished); Fleten, N., Johnsen, R., Reducing sick leave by minimal postal intervention: a randomised, controlled intervention study (2006) Occupational and Environmental Medicine, 63, pp. 676-682; Hammond, A., Young, A., Kidao, R., A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis (2004) Ann Rheum Dis, 63, pp. 23-30; Ince, G., Sarpel, T., Durgun, B., Erdogan, S., Effects of a multimodal exercise program for people with ankylosing spondylitis (2006) Phys Ther, 86, pp. 924-935; Macedo, A.M., Oakley, S.P., Panayi, G.S., Kirkham, B.W., Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy (2009) Arthritis Rheum, 61, pp. 1522-1530; Baldwin, D., Johnstone, B., Ge, B., Hewett, J., Smith, M., Sharp, G., Randomized prospective study of a work place ergonomic intervention for individuals with rheumatoid arthritis and osteoarthritis (2012) Arthritis Care Res (Hoboken), 64, pp. 1527-1535; Saltychev, M., Laimi, K., Pentti, J., Kivimäki, M., Vahtera, J., Short-and long-term changes in perceived work ability after interdisciplinary rehabilitation of chronic musculoskeletal disorders: prospective cohort study among 854 rehabilitants (2014) Clin Reha bil, 28, pp. 592-603; van Eren, M., Boot, C.R., Twisk, J.W., Steenbeek, R., Voskuyl, A.E., van Schaardenburg, D., Anema, J.R., One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis. Results of a Randomized Controlled Trial (2016) J Occup Rehabil, , Apr 7. [Epub ahead of print]; van Vilsteren, M., Boot, C.R., Twisk, J.W., van Schaardenburg, D., Steenbeek, R., Voskuyl, A.E., Anema, J.R., Effectiveness of an integrated care intervention on supervisor support and work functioning of workers with rheumatoid arthritis (2016) Disabil Rehabil, 21, pp. 1-9. , [Epub ahead of print]; AlHeresh, R., Vaughan, M., LaValley, M.P., Coster, W., Keysor, J.J., Criti-cal appraisal of the quality of literature evaluating psychome tric properties of arthritis work outcome assessments: A systema tic review (2016) Arthritis Care Res (Hoboken), 68, pp. 1354-1370; http://www.fitforworkeurope.eu/; http://www.portugalapto.pt/UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030452393&partnerID=40&md5=3e7804ec6a9bb7fc9c48b2fe68228706
PY - 2017/7
Y1 - 2017/7
N2 - Introduction: Aging of the population and early retirement translates into productivity losses to society. Persistence of working life is crucial to counteract this sustainability issue faced by western countries. Musculoskeletal and rheumatic diseases (RD) may cause work disability and early exit from work, including early retirement. The objective of this article is to review the current knowledge about interventions aiming to reduce early retirement due to RD. Methods:We searched PubMed and The Cochrane Library for studies either in English or Portuguese between January 2000 and June 2016 that evaluated the impact of interventions targeting early retirement in RD patients still at work. We also searched for grey literature from Portuguese institutional repositories. Results: We identified several published studies tes - ting pharmacologic and non-pharmacologic vocatio - nal rehabilitation interventions. None was specifically identified for Portugal. The general low quality of the literature and its inconsistency makes it unfeasible to draw definitive conclusions. However, some broad re - commendations might be outlined. An effective intervention must: 1) act upon different levels (e.g. RD patient, workplace), involving several stakeholders (e.g. rheumatologists, occupational physicians, employers); 2) prioritize the right patients (e.g. more disabling RD); and 3) consider the patients' role, for instance by including an element of patient education and support. Despite the lack of good quality evidence on this field, there seems to be a growing interest in the internatio - nal scientific community with several ongoing studies promoting such interventions. This promising data will be very useful to set up effective policies. Conclusions: This article summarizes the current knowledge about the impact of interventions to avoid or mitigate early retirement in RD patients. It highlights the demand for further research and it also contributes to aware decision-makers about the relevance of this topic, particularly in Portugal.
AB - Introduction: Aging of the population and early retirement translates into productivity losses to society. Persistence of working life is crucial to counteract this sustainability issue faced by western countries. Musculoskeletal and rheumatic diseases (RD) may cause work disability and early exit from work, including early retirement. The objective of this article is to review the current knowledge about interventions aiming to reduce early retirement due to RD. Methods:We searched PubMed and The Cochrane Library for studies either in English or Portuguese between January 2000 and June 2016 that evaluated the impact of interventions targeting early retirement in RD patients still at work. We also searched for grey literature from Portuguese institutional repositories. Results: We identified several published studies tes - ting pharmacologic and non-pharmacologic vocatio - nal rehabilitation interventions. None was specifically identified for Portugal. The general low quality of the literature and its inconsistency makes it unfeasible to draw definitive conclusions. However, some broad re - commendations might be outlined. An effective intervention must: 1) act upon different levels (e.g. RD patient, workplace), involving several stakeholders (e.g. rheumatologists, occupational physicians, employers); 2) prioritize the right patients (e.g. more disabling RD); and 3) consider the patients' role, for instance by including an element of patient education and support. Despite the lack of good quality evidence on this field, there seems to be a growing interest in the internatio - nal scientific community with several ongoing studies promoting such interventions. This promising data will be very useful to set up effective policies. Conclusions: This article summarizes the current knowledge about the impact of interventions to avoid or mitigate early retirement in RD patients. It highlights the demand for further research and it also contributes to aware decision-makers about the relevance of this topic, particularly in Portugal.
KW - Early exit from work
KW - Early retirement
KW - Rheumatic diseases
KW - Vocational rehabilitation
M3 - Review article
C2 - 28371796
SN - 0303-464X
VL - 2017
SP - 240
EP - 248
JO - Acta Reumatológica Portuguesa
JF - Acta Reumatológica Portuguesa
IS - 3
ER -